A pancreatic cancer team may use words such as resectable, borderline resectable, locally advanced, or metastatic. These terms help explain whether an operation could remove the cancer and how other treatments fit into the plan.
They are not simply another set of stage numbers. They describe practical treatment considerations, including the cancer's relationship to nearby structures and whether it has spread.
What the categories mean
Resectable generally means the team believes the cancer can be removed surgically. Borderline resectable means features such as involvement of nearby blood vessels make complete removal uncertain or difficult; treatment before surgery may be considered.
Locally advanced, unresectable cancer involves nearby structures in a way that prevents complete surgical removal, without distant spread. Metastatic cancer has spread to distant parts of the body.
ACS describes treatment according to pancreatic cancer extent. These categories require specialist assessment. Do not assign one to yourself from a single sentence in an imaging report.
Ask what evidence supports the classification
Request an explanation of the relevant scan findings and whether a pancreatic surgeon has reviewed them. Ask whether the team has enough information or expects additional imaging, biopsy results, or specialist discussion.
Write down the category in the clinician's words. Then ask: “Which finding makes surgery feasible or difficult?” This connects the label to the actual decision.
The person's overall health and ability to tolerate treatment also matter. An operation may be technically possible but still require a discussion of risks, benefits, and alternatives.
Understand the goal of treatment before surgery
Treatment given before surgery is called neoadjuvant treatment. The team may recommend it for particular resectable or borderline resectable situations. NCI's pancreatic treatment summary describes these approaches and ongoing evidence.
Ask what the treatment is expected to accomplish and how the team will reassess the plan. A useful question is: “After this phase, which results will determine whether surgery is appropriate?”
Receiving treatment first does not guarantee that an operation will follow. Conversely, a current classification may be revisited when new information is available. Request a realistic explanation of both possibilities.
Separate cancer treatment from symptom support
If surgery to remove the cancer is not recommended, ask what treatments are available and what their goals are. Support for pain, digestion, jaundice, nutrition, and emotional distress remains part of care.
Ask who manages symptoms while treatment decisions are being made. A person can need symptom support even when the next cancer treatment is still being arranged.
Do not interpret the absence of a surgery date as the absence of a care plan. Request a written next step and a route for problems during the waiting period.
Build a decision summary
After the appointment, record:
- The classification and the findings behind it.
- The current treatment goal.
- The next treatment or consultation.
- The date or event that triggers reassessment.
- Who communicates the results.
- Whether a second opinion or clinical-trial discussion is useful.
For a second opinion, ask whether the receiving center needs the actual scans and pathology material. Transfer those records rather than relying only on a short summary.
The purpose of these terms is to organize decisions. Understanding the reasoning, the goal, and the next reassessment is more useful than memorizing a category without context.
